ESR1 and neoplasm with perivascular epithelioid cell differentiation: ER overexpression was seen in 47.8% of ESS, 23.0% of non-uterine LMS, 60.3% of uterine LMS and 23.5% of PEComas (Figure 1c and Supplementary Table 1).